Our focus

We are a pharmaceutical company with an original mindset driven by science and inspired by patient needs, with a strong focus on gastrointestinal and liver diseases where unmet medical needs remain significant.

Porfolio
1989 year of establishment
PRAGUE CZECH REPUBLIC
our headquarters

Our products

Our portfolio of value-added generic medicines primarily addresses the problems of patients with gastrointestinal and hepatobiliary tract diseases, as well as metabolic health conditions.

Key products + more than 30 other medicial products.

Our key brands

Development

Our Development centre, based in Prague, drives the company‘s Innovation pipeline – from early Development to post-approval lifecycle management. We combine scientific excellence, regulatory expertise and efficient execution.

Partnership

Global code of conduct

At PRO.MED.CS, we recognize that ethical behavior and responsible business practices are essential to achieving sustainable success. Our Code of Conduct provides the framework that guides our actions, helping us maintain high standards and honor our responsibilities to employees, partners, customers, and communities.

Global code of conduct
"/>
PRO.MED.CS WORLDWIDE

Locations

We market our medicinal products in more than thirty countries via our own branch network in Europe and the Eurasian Economic Union and through partners in the rest of the world. Hand-in-hand with our company’s growth, we seek opportunities to expand our portfolio and presence around the world.

Australia Austria Azerbaijan Belarus Belgium Bosnia and Herzegovina Croatia Czech Republic Estonia Finland Georgia Germany Ireland Italy Kazakhstan Kyrgyzstan Latvia Lithuania Luxembourg Malaysia Mexico Moldova Mongolia Netherlands New Zealand Philippines Poland Russian Federation Singapore Slovakia Sweden Tunisia Ukraine United Arab Emirates United Kingdom Uzbekistan Vietnam

We are a fully integrated company

With primary ownership and control of all critical value-chain capabilities.

In-house Development

complemented by strategic partnership in co-development & in-licensing

In-house Production

complemented by strategic partnership with contract manufacturing organisations (CMO's)

In-house Sales, Medical & Marketing

complemented by strategic partnership in distribution and promotion

Our history

From small start-up to international business

The company was established on 1 February 1989 and launched its first medicine the following year. Obtaining the international certificate of Good Manufacturing Practice led to its dynamic growth in foreign markets.

Although the company has grown and expanded operations worldwide, we remain as committed as ever to high-quality manufacturing and processes that put our customers first. Like a good family, we care about the future, prosperity, satisfaction, and health of our employees.

1989
The company established in Prague
1992
Ursosan registered in Czechoslovakia markets
1994
GMP certificate obtained for production facilities in Prague
1996
International expansion to Russia, Poland and Kazakhstan
2000
GDP certificate received
2010
Portfolio extended to 20 brands
2012
International expansion to Germany
2017
GMP certificate approval in Russia
2019
First launch in UK market
2020
Portfolio extended to 50 brands marketed in 20 markets
2024
EAEU GMP approval
2025
GMP certificate approval by Saudi FDA
2025
Entry into Mexico

We help where it‘s needed – with heart and purpose

Each year, we support dozens of projects selected with employee involvement. We believe a helping hand can change a life.